Tang S and Lai KN |
Quiz page. Posttransplantation lymphoproliferative disorder (PTLD) involving the brain and the allograft. |
2005 |
Am. J. Kidney Dis. |
pmid:15806458
|
Rao PS |
Nephrotic syndrome in patients with peripheral blood stem cell transplant. |
2005 |
Am. J. Kidney Dis. |
pmid:15806483
|
de Mattos AM et al. |
Nephrotoxicity of immunosuppressive drugs: long-term consequences and challenges for the future. |
2000 |
Am. J. Kidney Dis. |
pmid:10676738
|
Kooman JP et al. |
A comparison between office and ambulatory blood pressure measurements in renal transplant patients with chronic transplant nephropathy. |
2001 |
Am. J. Kidney Dis. |
pmid:11382685
|
Choudhry S et al. |
Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial. |
2009 |
Am. J. Kidney Dis. |
pmid:19268410
|
Birdwell KA et al. |
Decreased antibody response to influenza vaccination in kidney transplant recipients: a prospective cohort study. |
2009 |
Am. J. Kidney Dis. |
pmid:19185404
|
Haas M et al. |
Smooth muscle-specific actin levels in the urine of renal transplant recipients: correlation with cyclosporine or tacrolimus nephrotoxicity. |
1999 |
Am. J. Kidney Dis. |
pmid:10401019
|
Wong TY et al. |
Parvovirus B19 infection causing red cell aplasia in renal transplantation on tacrolimus. |
1999 |
Am. J. Kidney Dis. |
pmid:10585325
|
Hricik DE |
Safety and efficacy of TOR inhibitors and other immunosuppressive regimens in African-American renal transplant recipients. |
2001 |
Am. J. Kidney Dis. |
pmid:11583939
|
Pescovitz MD and Govani M |
Sirolimus and mycophenolate mofetil for calcineurin-free immunosuppression in renal transplant recipients. |
2001 |
Am. J. Kidney Dis. |
pmid:11583940
|
Tang S et al. |
Use of tacrolimus in steroid- and cyclophosphamide-resistant minimal change nephrotic syndrome. |
2003 |
Am. J. Kidney Dis. |
pmid:14582073
|
Pham PT et al. |
Cyclosporine and tacrolimus-associated thrombotic microangiopathy. |
2000 |
Am. J. Kidney Dis. |
pmid:11007689
|
Revelo MP et al. |
A 14-year-old boy with kidney allograft failure in the first month after transplantation. |
2000 |
Am. J. Kidney Dis. |
pmid:11007695
|
Lien YH and Bracamonte ER |
Quiz page February 2011: acute kidney injury, graft pain, and subtherapeutic levels of tacrolimus. |
2011 |
Am. J. Kidney Dis. |
pmid:21251536
|
Pavan M et al. |
Altered bioavailability of tacrolimus following intravenous administration of tigecycline. |
2011 |
Am. J. Kidney Dis. |
pmid:21251548
|
Vischini G et al. |
Increased plasma levels of tacrolimus after ingestion of green tea. |
2011 |
Am. J. Kidney Dis. |
pmid:21787983
|
Wong KM et al. |
Abbreviated tacrolimus area-under-the-curve monitoring for renal transplant recipients. |
2000 |
Am. J. Kidney Dis. |
pmid:10739787
|
Böhmig GA et al. |
Role of humoral immune reactions as target for antirejection therapy in recipients of a spousal-donor kidney graft. |
2000 |
Am. J. Kidney Dis. |
pmid:10739788
|
Starzl TE et al. |
Tacrolimus (FK506) and the pharmaceutical/academic/regulatory gauntlet. |
1998 |
Am. J. Kidney Dis. |
pmid:9631858
|
Li X et al. |
Tacrolimus therapy in adults with steroid- and cyclophosphamide-resistant nephrotic syndrome and normal or mildly reduced GFR. |
2009 |
Am. J. Kidney Dis. |
pmid:19406543
|
Al-Awwa IA et al. |
Importance of allograft biopsy in renal transplant recipients: correlation between clinical and histological diagnosis. |
1998 |
Am. J. Kidney Dis. |
pmid:9631859
|
Lum EL et al. |
Acute Kidney Allograft Rejection Precipitated by Lenalidomide Treatment for Multiple Myeloma. |
2017 |
Am. J. Kidney Dis. |
pmid:28189378
|
Neylan JF et al. |
Assessment of the frequency and costs of posttransplantation hospitalizations in patients receiving tacrolimus versus cyclosporine. |
1998 |
Am. J. Kidney Dis. |
pmid:9820446
|
Chen W et al. |
Short-term outcomes of induction therapy with tacrolimus versus cyclophosphamide for active lupus nephritis: A multicenter randomized clinical trial. |
2011 |
Am. J. Kidney Dis. |
pmid:21177013
|
First MR |
Renal transplantation for the nephrologist: new immunosuppressive drugs. |
1992 |
Am. J. Kidney Dis. |
pmid:1371201
|
Paoletti E et al. |
ACE inhibitors and persistent left ventricular hypertrophy after renal transplantation: a randomized clinical trial. |
2007 |
Am. J. Kidney Dis. |
pmid:17591533
|
Mertz D et al. |
Drug-drug interaction in a kidney transplant recipient receiving HIV salvage therapy and tacrolimus. |
2009 |
Am. J. Kidney Dis. |
pmid:19346040
|
Israni A et al. |
Conversion to tacrolimus for the treatment of cyclosporine-associated nephrotoxicity in heart transplant recipients. |
2002 |
Am. J. Kidney Dis. |
pmid:11877596
|
Soi V et al. |
Altered mental status in a kidney transplant recipient receiving tacrolimus. |
2008 |
Am. J. Kidney Dis. |
pmid:18155524
|
Mathis AS and Friedman GS |
Coadministration of digoxin with itraconazole in renal transplant recipients. |
2001 |
Am. J. Kidney Dis. |
pmid:11157404
|
Asif A et al. |
Peritoneoscopic placement of peritoneal dialysis catheter and bowel perforation: experience of an interventional nephrology program. |
2003 |
Am. J. Kidney Dis. |
pmid:14655200
|
Grinyó JM et al. |
Safety and Efficacy Outcomes 3 Years After Switching to Belatacept From a Calcineurin Inhibitor in Kidney Transplant Recipients: Results From a Phase 2 Randomized Trial. |
2017 |
Am. J. Kidney Dis. |
pmid:27889299
|
Lien YH |
Top 10 Things Primary Care Physicians Should Know About Maintenance Immunosuppression for Transplant Recipients. |
2016 |
Am. J. Med. |
pmid:26714210
|
Bar J et al. |
Is immunosuppression therapy in renal allograft recipients teratogenic? A single-center experience. |
2003 |
Am. J. Med. Genet. A |
pmid:12476448
|
Perez-Aytes A et al. |
In utero exposure to mycophenolate mofetil: a characteristic phenotype? |
2008 |
Am. J. Med. Genet. A |
pmid:18074358
|
Chen W et al. |
Outcomes of tacrolimus therapy in adults with refractory membranous nephrotic syndrome: a prospective, multicenter clinical trial. |
2013 |
Am. J. Med. Sci. |
pmid:22627258
|
Hsu MS et al. |
Clinical features and outcome of tuberculosis in solid organ transplant recipients. |
2007 |
Am. J. Med. Sci. |
pmid:17700199
|
Ocampo-Garza J et al. |
Acquired Hyperpigmentation and Cicatricial Alopecia. |
2016 |
Am. J. Med. Sci. |
pmid:27524226
|
Chen M et al. |
Tacrolimus combined with corticosteroids in treatment of nephrotic idiopathic membranous nephropathy: a multicenter randomized controlled trial. |
2010 |
Am. J. Med. Sci. |
pmid:20220333
|
Ren H et al. |
Tacrolimus versus cyclophosphamide in steroid-dependent or steroid-resistant focal segmental glomerulosclerosis: a randomized controlled trial. |
2013 |
Am. J. Nephrol. |
pmid:23343906
|
Bhimma R et al. |
Management of steroid-resistant focal segmental glomerulosclerosis in children using tacrolimus. |
2006 |
Am. J. Nephrol. |
pmid:17159342
|
Issa N et al. |
Calcineurin inhibitor nephrotoxicity: a review and perspective of the evidence. |
2013 |
Am. J. Nephrol. |
pmid:23796509
|
Taber DJ et al. |
Significant racial differences in the key factors associated with early graft loss in kidney transplant recipients. |
2014 |
Am. J. Nephrol. |
pmid:24969370
|
Vural A et al. |
Assessment of oxidative stress in the early posttransplant period: comparison of cyclosporine A and tacrolimus-based regimens. |
2005 May-Jun |
Am. J. Nephrol. |
pmid:15925859
|
Li J et al. |
Evaluation of mycophenolic acid exposure using a limited sampling strategy in renal transplant recipients. |
2013 |
Am. J. Nephrol. |
pmid:23689735
|
Lee CT et al. |
Effects of cyclosporine, tacrolimus and rapamycin on renal calcium transport and vitamin D metabolism. |
2011 |
Am. J. Nephrol. |
pmid:21691056
|
Dai DS et al. |
Protective Effect of Salvia Przewalskii Extract on Puromycin-Induced Podocyte Injury. |
2015 |
Am. J. Nephrol. |
pmid:26439819
|
El-Dahshan KF et al. |
Ketoconazole-tacrolimus coadministration in kidney transplant recipients: two-year results of a prospective randomized study. |
2006 |
Am. J. Nephrol. |
pmid:16804292
|
Jin J et al. |
Klotho Deficiency Aggravates Tacrolimus-Induced Renal Injury via the Phosphatidylinositol 3-Kinase-Akt-Forkhead Box Protein O Pathway. |
2016 |
Am. J. Nephrol. |
pmid:27174564
|
Weir MR et al. |
Late calcineurin inhibitor withdrawal as a strategy to prevent graft loss in patients with suboptimal kidney transplant function. |
2004 Jul-Aug |
Am. J. Nephrol. |
pmid:15237243
|